SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15050950
Source:
http://linkedlifedata.com/resource/pubmed/id/15050950
Search
Subject
(
45
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0014822
,
umls-concept:C0449911
,
umls-concept:C1552961
pubmed:issue
4
pubmed:dateCreated
2004-3-30
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15050950-12901958
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100957246
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Erythropoietin
,
http://linkedlifedata.com/resource/pubmed/chemical/Hematinics
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/epoetin alfa
,
http://linkedlifedata.com/resource/pubmed/chemical/epoetin beta
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1470-2045
pubmed:author
pubmed-author:PerlmutterRoger MRM
,
pubmed-author:SeidenbergBethB
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
206-7
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:15050950-Anemia
,
pubmed-meshheading:15050950-Disease Progression
,
pubmed-meshheading:15050950-Drug Industry
,
pubmed-meshheading:15050950-Erythropoietin
,
pubmed-meshheading:15050950-Health Policy
,
pubmed-meshheading:15050950-Hematinics
,
pubmed-meshheading:15050950-Humans
,
pubmed-meshheading:15050950-Marketing
,
pubmed-meshheading:15050950-Randomized Controlled Trials as Topic
,
pubmed-meshheading:15050950-Recombinant Proteins
,
pubmed-meshheading:15050950-Safety
,
pubmed-meshheading:15050950-Societies, Medical
,
pubmed-meshheading:15050950-Survival Analysis
,
pubmed-meshheading:15050950-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
Amgen's point of view on epoetins.
pubmed:affiliation
Global Development, Amgen, Thousand Oaks, CA, USA.
pubmed:publicationType
Journal Article
,
Comment